β-基酸盐:一种用于各种疾病的补充分子
Navid Reza Shahtaghi1, Bindu Soni1, Hossamaldeen Bakrey1
1Department of Pharmaceutical Sciences, Guru Nanak Dev University, 143005, Amritsar, Punjab, India.
Current drug targets
|September 6, 2024
概括
补充β-基酸盐 (BHB) 可以诱导营养症以获得能量. 这篇评论探讨了 BHB 的情况.
科学领域:
- 代谢生物化学 代谢生物化学
- 营养科学 营养科学
- 蜂信号传输是如何进行的
背景情况:
- β-基酸盐 (BHB) 是一种体,被用于作为大脑和心脏等组织的替代能源.
- BHB的功能既是代谢中间体,也是信号分子,影响细胞和生理功能.
- 补充BHB是一种在没有严格饮食的情况下实现营养症的策略.
研究的目的:
- 审查BHB代谢及其治疗应用,特别是在与年龄有关的疾病中.
- 综合关于BHB在各种健康状况中的潜在益处和挑战的发现.
- 概述BHB补充剂的未来研究方向.
主要方法:
- 在PubMed,ScienceDirect和其他相关数据库中进行全面的文献搜索.
- 综合和讨论现有英语文章的发现.
- 分析 BHB 的机制,好处,挑战和未来前景.
主要成果:
- 补充BHB显示了神经退行性疾病,心血管疾病,癌症和炎症的潜在益处.
- BHB通过各种机制发挥其作用,包括受体相互作用,酶调节和表观遗传修饰.
- 挑战包括确定最佳剂量,确保安全性和确定有效配方.
结论:
- 补充BHB是健康研究的一个有希望的领域,有可能提高福祉和寿命.
- 需要进一步的研究来优化策略,了解分子机制,并评估长期效益.
- BHB提供了一种新的方法来管理各种疾病并改善健康状况.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
Regulation of Metabolism
9.3K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Overview of Lipid Metabolism
1.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.2K


